(VIANEWS) – The NASDAQ opens in less than three hours and Xenetic Biosciences‘s pre-market value is already 8.66% down.

The last session, NASDAQ ended with Xenetic Biosciences (XBIO) rising 2.38% to $0.74. NASDAQ fell 2.98% to $11,181.54, after two sequential sessions in a row of losses, on what was an all-around down trend trading session.


Today’s last reported volume for Xenetic Biosciences is 22486, 87.19% below its average volume of 175650.

Xenetic Biosciences’s last close was $0.74, 86.98% below its 52-week high of $5.68.

Xenetic Biosciences’s Revenue

Year-on-year quarterly revenue growth grew by 154.7%, now sitting on 746.09k for the twelve trailing months.


Xenetic Biosciences’s last day, last week, and last month’s current intraday variation average was 2.31%, 3.61%, and 2.32%, respectively.

Xenetic Biosciences’s highest amplitude of average volatility was 5.10% (day), 7.53% (last week), and 5.05% (last month), respectively.

More news about Xenetic Biosciences (XBIO).


Please enter your comment!
Please enter your name here